2021-04-20
Pancreatic Neuroendocrine Neoplasms: from Genetics to Everolimus Resistance
Publication
Publication
Pancreatische neuroendocriene neoplasieën: van genetica tot everolimusresistentie
Pancreatic neuroendocrine neoplasms are rare tumors of which the genetic constitution is not fully understood. In addition, resistance against everolimus, a frequently used treatment modality, forms a clinical challenge in these tumors. This thesis contains studies on the genetic make-up of pancreatic neuroendocrine tumors, the mechanisms of everolimus resistance and how to overcome this resistance.
Additional Metadata | |
---|---|
, , , , , , , , , , , , | |
L.J. Hofland (Leo) , P. Pauwels (Patrick) , M. Peeters (Marc) , K.O. de Beeck (Ken Op) | |
hdl.handle.net/1765/135471 | |
Organisation | Department of Internal Medicine |
Vandamme, T. (2021, April 20). Pancreatic Neuroendocrine Neoplasms: from Genetics to Everolimus Resistance. Retrieved from http://hdl.handle.net/1765/135471 |